Professor José Penadés appointed as new Director of the MRC CMBI
Professor José Penadés has been appointed as Director of the MRC Centre for Molecular Bacteriology and Infection (CMBI), commencing 1 July 2020.
Free COVID-19 online course re-launches to learners worldwide
Imperial researchers and Coursera have partnered to offer a free Massively Open Online Course explaining the science behind coronavirus.
Imperial's MRC CMBI receives five-year funding boost
An Imperial centre dedicated to the study of disease-causing bacteria has secured significant new funding to continue its work on to 2022.
Deadly amphibian plague can infect young zebrafish, scientists discover
The deadly chytrid fungus has for the first time been found to infect and kill species other than amphibians, giving clues on how it causes disease.
Agilent join Imperial's fight against TB and antimicrobial resistance
Agilent Technologies (UK) have entered into partnership with Imperial College London through the loan of a state-of-the-art Time of Flight Machine.
Multidisciplinary research project to tackle AMR formed at EMBRACE sandpit
Over 30 investigators gathered to find new ideas to tackle the growing problem of Antimicrobial Resistance at the EMBRACE sandpit
Faculty of Medicine gives insight into its exceptional translational research
A snapshot of our world-class translational medical research captured through 13 videos.
Feature
MRC celebrates centenary with poll on past and future of medicine
The Medical Research Council celebrates its 100th Birthday this year with a look back at the past and a gaze into the future of medical innovation.
Modified bacteria could be used in vaccines
A modified strain of Salmonella could be used to efficiently deliver antigens, the key ingredients of vaccines, into human cells, a study suggests.
1
Peter's test 7
Summary
